HCPCS Code A4208: Sterile syringe billing guide

Key Takeaways

HCPCS Code A4208 describes a sterile syringe with needle, 3 cc, billed per unit under HCPCS Level II

A4208 is reimbursed under Medicare Part B as a DMEPOS supply item, and rates vary by MAC jurisdiction

Modifiers KX, GA, and GZ may apply; incorrect modifier use is a common denial trigger for this code

Practice management software with billing tools, like Pabau, supports HCPCS Level II code entry and supply documentation for codes like A4208

HCPCS Code A4208 is a Level II supply code for a sterile syringe with needle, 3 cc, billed per unit under Medicare Part B and Medicaid.

It sits within the A4206-A4232 injection and infusion supplies range maintained by the Centers for Medicare and Medicaid Services (CMS), and each code in that range carries a distinct descriptor. This guide covers the official descriptor, fee schedule, Medicare coverage criteria, applicable modifiers, related crosswalk codes, and documentation requirements for accurate A4208 billing.

HCPCS Code A4208: definition and official descriptor

HCPCS Code A4208 is a Level II HCPCS code maintained by CMS. Its official descriptor is: Syringe with needle, sterile, 3 cc, each. The word “each” is not incidental. It defines the billing unit. Bill every syringe dispensed as a separate unit, so a claim for ten syringes requires a quantity of 10, not a single line item.

A4208 sits within the injection and infusion supplies range A4206-A4232, classified under Miscellaneous Medical Supplies for DMEPOS (Durable Medical Equipment, Prosthetics, Orthotics, and Supplies) billing purposes. It applies to Medicare Part B and Medicaid claims for qualifying patients receiving covered injectable therapies.

Clinical use cases for A4208

The 3 cc syringe occupies a specific clinical niche. It is large enough for most single-dose injectable medications and small enough to allow precise volume control, making it one of the most commonly stocked syringes in outpatient and home-care settings.

Common clinical scenarios where A4208 applies include vaccine administration workflows requiring a sterile syringe per dose, and supply provision for patients receiving injectable biologics or hormone therapies covered under Part B. Medicare Part D covers at-home, self-administered insulin syringes instead, not this DMEPOS benefit.

Facilities running IV therapy clinic best practices frequently stock 3 cc syringes for medication flush protocols alongside larger infusion equipment.

• Non-insulin injectable therapies: Part B-covered biologic or hormone injections requiring a 3 cc syringe; at-home insulin syringes are a separate Part D pharmacy benefit, not billed under A4208
• Vaccine administration: syringe supply for immunizations administered outside the physician office, such as a DMEPOS supplier shipment; in most in-office visits the syringe is bundled into the vaccine administration code rather than billed separately under A4208
• Injectable medications: Testosterone, B12, corticosteroid, and similar depot injections administered in outpatient settings
• IV therapy flush supplies: 3 cc syringes used in heparin or saline flush protocols at infusion clinics
• Home health supply provisions: DMEPOS supplier shipments of syringes to homebound Medicare beneficiaries

Note that A4208 describes the supply only, not the injection procedure itself. Bill the procedure code (CPT or a separate HCPCS code) independently on the same claim where applicable. A joint injection billed under CPT 20605, for example, is reported separately from the syringe supply itself.

How to bill HCPCS Code A4208

Billing A4208 correctly comes down to three fundamentals: accurate quantity reporting, correct place of service, and appropriate modifier selection. Getting any one of these wrong triggers a denial that takes time to appeal.

Practice management software with billing tools, like Pabau, supports HCPCS Level II code entry so billers can record A4208 alongside procedure codes without switching between systems. Its claims management software reduces manual transcription errors on supply-heavy billing workflows.

1. Enter the code and quantity: Use A4208 on the claim with the exact number of syringes supplied in the quantity field. Bill per unit. Do not bundle multiple syringes into a single unit entry.
2. Select the correct place of service: For DMEPOS claims, place of service is typically the patient’s home (POS 12) when the supplier ships syringes directly. For outpatient facility supply, use the applicable facility POS code.
3. Apply modifiers as required: Medicare requires modifier KX when the supply meets coverage criteria documented in the medical record. See the modifiers section below for full guidance.
4. Submit on the correct claim form: DMEPOS suppliers submit on CMS-1500. Institutional facilities use UB-04. The enrolled DMEPOS supplier NPI must match the billing entity on file with the MAC.
5. Retain supporting documentation: A written order from the treating physician or practitioner, along with proof of medical necessity, must be available before the claim is submitted, not produced for the first time during an audit.

A4208 fee schedule and reimbursement rates

The DMEPOS fee schedule sets Medicare reimbursement for A4208 rather than the Medicare Physician Fee Schedule, which prices physician services by RVU rather than DMEPOS supplies. CMS publishes rates annually, and they vary by MAC jurisdiction and state.

Syringe codes in the A4206-A4209 range are carrier-priced, meaning each DME MAC sets its own allowable using carrier judgment (BETOS classification) rather than one fixed, nationally published rate. Current allowables are available through the CMS DMEPOS fee schedule.

Because A4208 is a low-unit-cost supply item, the per-syringe Medicare allowable is typically a few cents to under one dollar, depending on jurisdiction. Practices billing high volumes, such as home health agencies or large infusion centers, see meaningful cumulative reimbursement. That only holds when unit quantities are documented and billed precisely.

Always pull the current DMEPOS fee schedule from the CMS website before submitting claims for any given fiscal year. Fee schedules effective January 1 each year replace prior-year rates. Billing at an outdated allowable does not protect you from recoupment if the claim overpays.

Medicare coverage criteria for A4208

Medicare Part B covers A4208 under the DMEPOS benefit when the syringe is medically necessary for a covered injectable drug or supply. Coverage is not automatic. A claim must meet specific conditions before Medicare pays it.

Practices serving Medicare beneficiaries should keep this checklist in their billing workflow. For facilities also managing medical spa billing software, understanding DMEPOS coverage rules prevents costly claim errors when injectable therapies cross into Part B territory.

• The beneficiary must be enrolled in Medicare Part B and be eligible for the DMEPOS benefit
• A physician or qualified non-physician practitioner must have issued a written order (prescription) for the supply prior to claim submission
• The syringe must be medically necessary for a specific covered use, such as immunization or another covered non-insulin injectable drug; at-home insulin syringes are a Part D benefit and are not billed under this Part B code
• The supplier must be enrolled as a DMEPOS supplier with the applicable MAC and must have a valid supplier number
• The supplier must maintain the original written order and proof of medical necessity in the patient file for a minimum of 7 years
• Quantity limits apply: CMS may restrict the number of units billable per claim period. Check current MAC Local Coverage Determinations (LCDs) for applicable limits

Coverage may also be subject to Local Coverage Determinations issued by the MAC for your jurisdiction. Always verify the applicable LCD before billing, as coverage criteria can vary between jurisdictions even for the same HCPCS code.

Simplify supply billing with Pabau

Pabau supports HCPCS Level II code entry and documentation alongside your clinical workflows. See how it handles supply billing for injection-based practices.

Book a demo

Applicable modifiers for A4208

Modifier selection for A4208 is where many supply claims go wrong. The three modifiers most commonly associated with DMEPOS supply codes in this range are KX, GA, and GZ. Each signals a different coverage determination to the payer.

Applying KX without the required documentation in place is a compliance risk. Medicare auditors specifically review KX-modified claims for supporting evidence. Confirm that modifier applicability for A4208 aligns with the most current MAC coverage article for your jurisdiction, as modifier requirements can be updated independently of the fee schedule.

Related and crosswalk codes

The A4206-A4232 range covers syringes and needles in different capacities. Selecting the wrong code in this range is a common coding error. Payers audit syringe codes for descriptor mismatches, and billing a 3 cc syringe under the 1 cc code is grounds for recoupment.

The same descriptor precision applies across other HCPCS Level II supply and device codes, from drainable ostomy pouches billed under A4425 to electrophysiology catheters under C1733.

The AAPC Codify HCPCS lookup provides a searchable reference for the full A-code range alongside descriptor comparisons. For fertility-related injectable procedures, see our guide on IVF CPT codes.

Crosswalk note: there is no direct ICD-10 crosswalk for supply codes like A4208 in the same way procedure codes map to diagnoses. Instead, the treating diagnosis on the claim must support medical necessity for the injectable supply. The diagnosis code validates that the syringe served a covered clinical purpose.

Documentation requirements and compliance tips

Missing documentation is the leading cause of DMEPOS claim recoupment on audit. Medicare auditors do not require that documentation be perfect. They require that it be present, dated, and specific. Practices that manage HIPAA compliance for medical offices alongside their billing operations are better positioned to maintain the records needed to defend A4208 claims.

The medical forms management process at your practice should capture the written order for each supply code before you dispense the first unit, not after the fact. Retroactive orders are among the most flagged compliance issues in DMEPOS audits.

• Written order: Must specify the supply, quantity, frequency, and duration. The ordering practitioner must sign and date it before delivery.
• Proof of delivery: For mail-order or shipped supplies, retain a signed delivery confirmation. For in-office dispensing, document the date, quantity, and lot number in the patient record.
• Medical necessity: The patient’s medical record must contain clinical notes explaining why the practitioner ordered the injectable supply. A diagnosis alone is not sufficient.
• Quantity documentation: Bill only the quantity dispensed, not the quantity prescribed. If a patient refuses part of a shipment, adjust the claim quantity accordingly.
• Retention period: CMS requires suppliers to retain DMEPOS documentation for 7 years from the date of service or date of claim, whichever is later.

For facilities subject to medical spa compliance requirements that include injectable services, aligning your supply billing documentation with your clinical consent and intake records reduces the risk of inconsistencies that attract audit attention.

How Pabau supports HCPCS supply code billing

Practices administering injectable therapies, from IV infusion centers to aesthetic practices offering B12 or hormone injections, often manage supply billing alongside procedure codes in the same patient encounter. Handling this in disconnected systems creates transcription errors and missed units.

Pabau lets practices record HCPCS Level II supply codes like A4208 at the point of care and attach them to the relevant clinical encounter, keeping quantity, modifier, and documentation together instead of reconciling separate systems after the fact.

For practices running IV therapy clinic software, supply tracking integrates with inventory so the units billed match the units consumed. That alignment is what makes A4208 quantity reporting defensible at audit. Pabau also supports digital intake forms that capture the clinical context and written-order information needed before supply codes are billed, reducing the retroactive documentation risk flagged above.

Understanding how practice management software handles supply coding alongside procedure billing helps practices choose tools that reduce manual reconciliation. For EMR software for IV therapy settings in particular, integrated supply billing keeps per-unit claim accuracy consistent across high-volume infusion days.

Continue your research

Need to track injectable supply compliance across your practice? Medical spa compliance guidance covers the documentation and audit-readiness requirements that apply to injection-based services.

Running an infusion clinic and managing high-volume supply billing? IV therapy clinic best practices details the operational and clinical documentation standards for infusion-based practices.

Billing the injectable drug alongside the syringe supply? HCPCS code J2795 covers billing ropivacaine hydrochloride injection, a drug commonly paired with a supply code like A4208.

Conclusion

Unit reporting errors, missing modifiers, and documentation that was not in place before the claim went out cause most A4208 denials. Using the wrong code is a less common culprit. Getting the descriptor right (3 cc, sterile, each) and matching the billed quantity to dispensed units is the foundation of clean claim submission for this supply code.

Pabau’s billing tools connect supply code entry to clinical encounters so the quantity, modifier, and supporting documentation are captured at the point of care. To see how it handles HCPCS Level II billing alongside your clinical workflows, book a demo.

Frequently asked questions